Related content

Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5′-UTR in patients with polycystic ovarian syndrome

By Marszalek B.   Laciński M.   Babych N.   Capla E.   Biernacka-Lukanty J.   Warenik-Szymankiewicz A.   Trzeciak W. H.  

Gynecological Endocrinology, Vol. 15, Iss. 2, 2001-04 ,pp. : 123-128

Informa Healthcare

Access to resources Recommend Favorite

A new compound heterozygous mutation in the CYP17A1 gene in a female with 17α-hydroxylase/17,20-lyase deficiency

By Lee Eun Sil  

Gynecological Endocrinology, Vol. 29, Iss. 7, 2013-07 ,pp. : 720-723

Informa Healthcare

Access to resources Recommend Favorite

CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility

By Kristiansen W.   Haugen T. B.   Witczak O.   Andersen J. M.   Fosså S. D.   Aschim E. L.  

International Journal of Andrology, Vol. 34, Iss. 1, 2011-02 ,pp. : 77-83

Blackwell Publishing

Access to resources Recommend Favorite

The CYP17 Msp A1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population

By Tsujino Taro   Ohara Noriyuki   Yoshida Shigeki   Kennedy Stephen   Takemura Naoya   Deguchi Masashi   Maruo Takeshi  

Gynecological Endocrinology, Vol. 22, Iss. 2, 2006-02 ,pp. : 87-91

Informa Healthcare

Access to resources Recommend Favorite

Homozygous CYP17A1 mutation (H373L) identified in a 46,XX female with combined 17α-hydroxylase/17,20-lyase deficiency

By Lee Mee-Hwa   Won Park Seok   Yoon Tae Ki   Shim Sung Han  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 573-576

Informa Healthcare

Access to resources Recommend Favorite